But	CC	O
in	IN	O
the	DT	B
largest	JJS	O
trial	NN	O
to	IN	B
date	NN	O
,	,	B
comparing	VBG	O
clomiphene	NN	O
with	IN	O
metformin	NN	O
,	,	B
clomiphene	NN	O
alone	RB	O
was	VBD	B
the	DT	I
most	RBS	B
effective	JJ	O
.	.	O

In	IN	O
this	DT	B
trial	NN	O
,	,	B
626	CD	O
women	NNS	O
were	VBD	B
randomized	VBN	O
to	IN	B
three	CD	O
groups	NNS	B
:	:	O
metformin	NN	O
alone	RB	O
,	,	B
clomiphene	NN	O
alone	RB	O
,	,	B
or	CC	I
both	DT	O
.	.	O

The	DT	B
live	JJ	O
-	HYPH	B
birth	NN	O
rates	NNS	O
following	VBG	O
6	CD	O
months	NNS	O
of	IN	B
treatment	NN	O
were	VBD	B
7.2	CD	O
%	NN	O
(	-LRB-	O
metformin	NN	O
)	-RRB-	O
,	,	B
22.5	CD	O
%	NN	O
(	-LRB-	O
clomiphene	NN	O
)	-RRB-	O
,	,	B
and	CC	I
26.8	CD	O
%	NN	O
(	-LRB-	O
both	DT	O
)	-RRB-	O
.	.	O

The	DT	B
major	JJ	I
complication	NN	O
of	IN	B
clomiphene	NN	O
was	VBD	B
multiple	JJ	O
pregnancy	NN	O
,	,	B
affecting	VBG	O
0	CD	O
%	NN	O
,	,	B
6	CD	O
%	NN	O
and	CC	B
3.1	CD	O
%	NN	O
of	IN	B
women	NNS	O
respectively	RB	O
.	.	O

Thus	RB	O
,	,	B
these	DT	I
were	VBD	B
women	NNS	O
with	IN	O
significant	JJ	B
fertility	NN	O
problems	NNS	O
,	,	B
and	CC	I
the	DT	B
live	JJ	O
-	HYPH	B
birth	NN	O
rates	NNS	O
are	VBP	B
probably	RB	I
not	RB	B
representative	NN	O
of	IN	B
the	DT	I
typical	JJ	O
PCOS	NNP	O
woman	NN	O
.	.	O

